Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[β- 11C]DOPA: A stabilizing effect for dopaminergic neurotransmission?

Journal of Neuroscience

Volumn 29, Issue 43, 2009, Pages 13730-13734

  Ito, Hiroshi ^a   Takano, Harumasa ^a   Takahashi, Hidehiko ^a   Arakawa, Ryosuke ^a   Miyoshi, Michie ^a   Kodaka, Fumitoshi ^a   Okumura, Masaki ^a   Otsuka, Tatsui ^a   Suhara, Tetsuya ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOPA; DOPAMINE; DOPAMINE 2 RECEPTOR; RACLOPRIDE C 11; RISPERIDONE;

ADULT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG ACTIVITY; HUMAN; HUMAN EXPERIMENT; MALE; NEUROTRANSMISSION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CARBON RADIOISOTOPES; CAUDATE NUCLEUS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOXAZOLES; LEVODOPA; MALE; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; PYRIMIDINES; RACLOPRIDE; RECEPTORS, DOPAMINE D2; REST; RISPERIDONE; SYNAPTIC TRANSMISSION; YOUNG ADULT;

EID: 70350554113     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4172-09.2009     Document Type: Article

References (43)

1. Balsara JJ, Jadhav JH, Chandorkar AG (1979) Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology (Berl) 62:67-69. (Pubitemid 9244816)
2. Baron JC, Martinot JL, Cambon H, Boulenger JP, Poirier MF, Caillard V, Blin J, Huret JD, Loc'h C, Maziere B (1989) Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology (Berl) 99:463-472.
3. Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ (1997) Performance evaluation of a whole-body PET scanner using the NEMA protocol. J Nucl Med 38:1614-1623. (Pubitemid 27443965)
4. Brown RM, Crane AM, Goldman PS (1979) Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates. Brain Res 168:133-150.
5. Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 20:140-144.
6. Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2008) Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 28:1208-1212. (Pubitemid 351186336)
7. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M (2009) Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci 29:1538-1543.
8. Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.
9. Cumming P, Ase A, Laliberté C, Kuwabara H, Gjedde A (1997) In vivo regulation of DOPA decarboxylase by dopamine receptors in rat brain. J Cereb Blood Flow Metab 17:1254-1260.
10. Danielsen EH, Smith D, Hermansen F, Gjedde A, Cumming P (2001) Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo. Synapse 41:172-175.
11. Davila R, Manero E, Zumarraga M, Andia I, Schweitzer JW, Friedhoff AJ (1988) Plasma homovanillic acid as a predictor of response to neuroleptics. Arch Gen Psychiatry 45:564-567. (Pubitemid 18147826)
12. Elsworth JD, Jentsch JD, Morrow BA, Redmond DE Jr, Roth RH (2008) Clozapine normalizes prefrontal cortex dopamine transmission in monkeys subchronically exposed to phencyclidine. Neuropsychopharmacology 33:491-496.
13. Farde L, Wiesel FA, Halldin C, Sedvall G (1988) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45:71-76. (Pubitemid 18018572)
14. Friston KJ, Frith CD, Liddle PF, Dolan RJ, Lammertsma AA, Frackowiak RS (1990) The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 10:458-466.
15. Gjedde A (1988) Exchange diffusion of large neutral amino acids between blood and brain. In: Peptide and amino acid transport mechanisms in the cerebral nervous system (Rakic L, Begley DJ, Davson H, Zlokovic BV, eds), pp 209-217. New York: Stockton.
16. Gjedde A, Reith J, Dyve S, Leger G, Guttman M, Diksic M, Evans A, Kuwabara H (1991) Dopa decarboxylase activity of the living human brain. Proc Natl Acad Sci U S A 88:2721-2725. (Pubitemid 21916490)
17. Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
18. Gründer G, Vernaleken I, Müller MJ, Davids E, Heydari N, Buchholz HG, Bartenstein P, Munk OL, Stoeter P, Wong DF, Gjedde A, Cumming P (2003) Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo. Neuropsychopharmacology 28:787-794.
19. 11C]dopa in humans studied by positron emission tomography. J Neural Transm Gen Sect 86:25-41.
20. Hertel P, Nomikos GG, Iurlo M, Svensson TH (1996) Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain. Psychopharmacology (Berl) 124:74-86. (Pubitemid 26112776)
21. Hicks PB (1990) The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci 47:1609-1615.
22. 11C]DOPA. Nucl Med Commun 27:723-731.
23. 11C]DOPA. Ann Nucl Med 21:355-360.
24. Korsgaard S, Gerlach J, Christensson E (1985) Behavioral aspects of serotonin-dopamine interaction in the monkey. Eur J Pharmacol 118:245-252. (Pubitemid 16179849)
25. Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153-158. (Pubitemid 27024284)
26. 11C] raclopride studies. J Cereb Blood Flow Metab 16:42-52.
27. Leysen JE, Janssen PM, Megens AA, Schotte A (1994) Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry 55 (Suppl):5-12.
28. Lloyd KG, Hornykiewicz O (1972) Occurrence and distribution of aromatic L-amino acid (L-DOPA) decarboxylase in the human brain. J Neurochem 19:1549-1559.
29. 18F]-L-m- tyrosine. Synapse 52:153-162.
30. 1A receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry 164:1411-1417.
31. 2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. Psychopharmacology (Berl) 110:265-272.
32. O'Keeffe R, Sharman DF, Vogt M (1970) Effect of drugs used in psychoses on cerebral dopamine metabolism. Br J Pharmacol 38:287-304.
33. Patlak CS, Blasberg RG (1985) Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5:584-590.
34. 2A antagonist, attenuates dopamine release in the rat medial prefrontal cortex. Brain Res 888:51-59.
35. Pickar D, Breier A, Kelsoe J (1988) Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients. Ann N Y Acad Sci 537:339-346. (Pubitemid 19029556)
36. Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719.
37. +-dependent uptake of the neurotransmitter candidate L-DOPA in the CNS. Neuroscience 104:1-14.
38. Torstenson R, Hartvig P, Långström B, Bastami S, Antoni G, Tedroff J (1998) Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone. Neuropharmacology 37:989-995. (Pubitemid 28401488)
39. 18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge. Neuroimage 30:1332-1339.
40. 18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: a positron emission tomography study in healthy subjects. Neuroimage 40:1222-1231.
41. Watson CC, Newport D, Casey ME (1996) A single scatter simulation technique for scatter correction in 3D PET. In: Three-dimensional image reconstruction in radiology and nuclear medicine (Grangeat P, Amans JL, eds), pp 255-268. Dordrecht, The Netherlands: Kluwer Academic Publishers.
42. Zhu MY, Juorio AV, Paterson IA, Boulton AA (1992) Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain. J Neurochem 58:636-641.
43. Zhu MY, Juorio AV, Paterson IA, Boulton AA (1993) Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors. Eur J Pharmacol 238:157-164. (Pubitemid 23214427)